These findings indicate that tumors with high S100A1 expression exhibited an immunologically “cold” TME characterized by a lack of T cell and proinflammatory M1 macrophage infiltration and that tumor-intrinsic S100A1 loss can remodel the TME to become more immunoactive. This evidence concerns the gene S100A1 and neoplasm.